What’s New

News Nov 18, 2024
Alimentiv Partners on a New Alcoholic Hepatitis Phase 1b Clinical Trial

September 2024 – Alimentiv is proud to partner on an exciting new Phase 1b clinical trial in severe alcohol-associated hepatitis, an area with high mortality…

Publication Nov 6, 2024
Efficacy and Safety of Advanced Combination Treatment in Immune-Mediated Inflammatory Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Christopher Ma, Vipul Jairath, Virginia Salitano

Publication Feb 19, 2021
Vedolizumab for the Treatment of Noninflammatory Bowel Disease Related Enteropathy

Christopher Ma, Vipul Jairath

Publication Dec 18, 2020
Early Combined Immunosuppression Reduces Complications in Long-standing Crohn’s Disease: A Post Hoc Analysis of REACT

Brian Feagan, Christopher Ma, Geert D’Haens, Guangyong Zou, Vipul Jairath

Publication Dec 15, 2020
Endoscopic Assessment of Inflammatory Bowel Disease Activity in Clinical Trials

Brian Feagan, Christopher Ma, Guangyong Zou, Niels Vande Casteele, Vipul Jairath

Publication Dec 3, 2020
Modeling Endoscopic Improvement after Induction Treatment With Mesalamine in Patients With Mild-to-Moderate Ulcerative Colitis

Brian Feagan, Christopher Ma, Claire E Parker, Geert D’Haens, Vipul Jairath

Publication Oct 5, 2020
Precision Medicine in IBD Clinical Research

Niels Vande Casteele, Vipul Jairath

Publication May 10, 2020
Safety of Combination Biologic and Antirejection Therapy Post-Liver Transplantation in Patients With Inflammatory Bowel Disease

Brian Feagan, Christopher Ma, Vipul Jairath